Sickle cell disease is an inherited disorder affecting the blood. Recently, promising new treatment strategies have emerged involving gene editing therapies and the administration of stem cells directly into the developing foetus in the womb. Along with his colleagues, Dr Panicos Shangaris at Kings College London, has conducted a comprehensive review of the available evidence to support this novel approach.